HARMONY BIOSCIENCES HOLDINGS (HRMY)

US4131971040 - Common Stock

29.8  +0.87 (+3.01%)

Buy % Consensus

77

ChartMill assigns a Buy % Consensus number of 77% to HRMY. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 42.46. This target is 42.47% above the current price.
HRMY was analyzed by 14 analysts. The buy percentage consensus is at 77. So analysts seem to be have mildly positive about HRMY.
In the previous month the buy percentage consensus was at a similar level.
HRMY was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 29.8030.3042.8442.4658.80 - 1.68% 43.76% 42.47% 97.32%
Up and Down Grades
Date Firm Action Rating
2024-04-12 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-04-11 Needham Reiterate Buy -> Buy
2024-04-09 Needham Reiterate Buy -> Buy
2024-03-28 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-02-27 Mizuho Maintains Buy -> Buy
2024-02-23 Cantor Fitzgerald Reiterate Overweight -> Overweight
2024-02-23 Needham Maintains Buy -> Buy
2024-02-22 Needham Reiterate Buy -> Buy
2024-02-16 Mizuho Maintains Buy -> Buy
2024-01-09 Goldman Sachs Maintains Sell -> Sell
2024-01-02 B of A Securities Downgrade Neutral -> Underperform
2023-11-01 Needham Reiterate Buy -> Buy
2023-11-01 Raymond James Maintains Outperform -> Outperform
2023-10-16 Needham Maintains Buy -> Buy
2023-10-16 Raymond James Maintains Outperform -> Outperform
2023-10-16 Piper Sandler Maintains Overweight -> Overweight
2023-10-04 Mizuho Reiterate Buy -> Buy
2023-09-26 Goldman Sachs Maintains Sell -> Sell
2023-09-25 Goldman Sachs Downgrade Neutral -> Sell
2023-09-22 Needham Reiterate Buy -> Buy
2023-09-19 Mizuho Maintains Buy -> Buy
2023-09-07 Berenberg Initiate Buy
2023-08-29 Mizuho Reiterate Buy -> Buy
2023-08-22 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-08-15 Needham Reiterate Buy -> Buy
2023-08-03 Mizuho Maintains Buy -> Buy
2023-08-02 Needham Reiterate Buy -> Buy
2023-08-02 Raymond James Maintains Outperform -> Outperform
2023-08-01 Needham Reiterate Buy -> Buy
2023-06-23 Cantor Fitzgerald Reiterate Overweight -> Overweight